Search
Review and highlight of the significant advances made towards vaccine development and understanding of the immunology of otitis media
The most urgent areas appear to be to continue monitoring the emergence of novel otopathogens, and the need to develop prevention and preventative therapies
We have demonstrated that a single dose of a closely related commensal can delay onset of NTHi otitis media in vivo
These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity
We observed an association between Type III DNA methyltransferase presence and Otitis Media-associated middle ear isolates
PCV10 did not reduce NTHi density in the nasopharynx or middle ear, and was associated with increased pneumococcal nasopharyngeal density
We have previously demonstrated that mice exposed to geogenic dust PM10 experienced an exacerbation of inflammatory responses to influenza A virus.
Respiratory viruses, particularly respiratory syncytial virus and human metapneumovirus, are major contributors to pneumonia in Australian children
Elevated antimicrobial proteins and peptides and cytokines in middle ear effusion are a marker of inflammation and bacterial persistence
Presence of bacterial otopathogen in the middle ear during ventilation tube insertion was a predictor of children at-risk of repeat ventilation tube insertion